GORE® logo

Trusted Performance Today and Tomorrow


EVAR

  • Trusted Performance

    Today2016

    GORE® EXCLUDER® Iliac Branch Endoprosthesis (IBE) is the
    only iliac branch solution to receive FDA approval

    250,000 clinical implants of GORE® EXCLUDER® Device
    Trunk-Ipsilateral Legs

    2015

    1,000 clinical implants
    of IBE

    2014

    Profile is reduced to
    16 Fr for 23 and 26 mm
    Trunk-Ipsilateral Legs and
    Aortic Extenders

    2013

    GORE® EXCLUDER® Iliac
    Branch Endoprosthesis
    received CE Mark

    2012

    CE Mark and FDA approval
    received for 35 mm
    Trunk-Ipsilateral Legs

    Profile of 31 mm
    Trunk-Ipsilateral Legs
    and larger Contralateral
    Legs are reduced

    2011

    23 and 27 mm Contralateral
    Leg introduced

    2010

    GORE® C3® Delivery System
    received CE Mark and FDA
    approval

    2009

    31 mm Trunk-Ipsilateral Legs
    received FDA approval

    2005

    Six 12 cm Trunk-Ipsilateral
    Leg configurations added

    2004

    A low permeability GORE®
    EXCLUDER® Device design
    introduced

    Three 14 cm Trunk-Ipsilateral
    Leg configurations added

    2003

    31 mm Trunk-Ipsilateral
    Legs launched in Europe

    Nine additional Contralateral
    Leg configurations added

    2002

    FDA approved the GORE®
    EXCLUDER® AAA Endoprosthesis

    1997

    The original GORE® EXCLUDER®
    AAA Endoprosthesis launched
    in Europe

TEVAR

Distinct Capabilities